The researcher and former OpenAI board member discusses who holds the advantage in artificial intelligence and the chances of the U.S. and China working together to regulate the technology.
When Congress resumes next month, the BioSecure Act will be one of its top priorities. The bill, which could dramatically reorder the global pharmaceutical supply chain, is the latest example of the U.S. trying to exorcize China from its supply chains, and it will have...
Confidential documents show that Xiao Jianhua, a corrupt investor tied to China’s political elite, backed the country’s most successful and revered entrepreneur.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy